The Readout Loud

Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the past? And how big can biotech get in China?

Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce "Martin Shkreli"?

Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?

What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?

Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call? We're coming up on the 100th episode of this podcast, and we're using the occasion to actualize our long-held dream of running a call-in show. Dial us at 617-517-6130 and leave a message with any question you'd like us to answer on the podcast, and you may just hear it on air in the coming weeks.

Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a "public health emergency of international concern?"

Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?

Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find?

Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine?

Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?

Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?

How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?

Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new drug?

Do you trust Google with your health data? Is "Gattaca" an outdated reference? And what's it like to get dunked on?

Why hope for China's new Alzheimer's drug turned into skepticism ? Is three a crowd in CAR-T? And what's a Bionomy?